Gsk (GSK) Cash from Discontinued Operations (2021 - 2022)
Gsk (GSK) posted Cash from Discontinued Operations of $4.7 million for Q4 2022, down 99.13% quarter-over-quarter from $540.8 million in Q1 2022, and down 99.38% YoY from $760.3 million in Q4 2021.
Powered by 
Analysis
Gsk (GSK) Cash from Discontinued Operations (2021 - 2022) Analysis & Trends
Gsk (GSK) has 2 years of Cash from Discontinued Operations data on file, last reported at $4.7 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.86 Bn | 602.88 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 361.40 Bn | 361.40 Bn | - | - |
| 3 | General Electric | 329.38 Bn | 320.03 Bn | 6.95 Bn | -64.00 Mn |
| 4 | Astrazeneca | 253.73 Bn | 248.44 Bn | 12.86 Bn | - |
| 5 | Citigroup | 228.07 Bn | -2,074.24 Bn | 24.75 Bn | - |
| 6 | Bhp | 216.09 Bn | 197.55 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.36 Bn | 195.32 Bn | - | - |
| 9 | Unilever | 139.15 Bn | 132.12 Bn | - | - |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 4.69 Mn |
| Mar 31, 2022 | 540.76 Mn |
| Dec 31, 2021 | 760.28 Mn |